Opiate tycoons sent $1 billion to Swiss banks: court files
September 14, 2019
The Sackler family, which owns OxyContin maker Purdue Pharma, is believed to have transferred about $1 billion (€900 million) to themselves, including to their Swiss bank accounts, court papers showed.
The Sackler family used Swiss and other hidden accounts to transfer $1 billion (€900 million) to themselves, New York State's attorney general said in court papers filed on Friday.
The information came out as the Sacklers and their company, Purdue Pharma, are in the process of reaching compensation agreements for those hurt by opioid painkillers.
The company and family sit at the heart of investigations into the US opioid abuse epidemic, facing accusations that they flooded US communities with prescription painkillers.
But New York and other states have promised they will continue to pursue the Sacklers, alleging that family members drained more than $4 billion from the company over the past 12 years.
The family has used a complex chain of companies and trusts to control their holdings, some located in offshore tax havens.
The Sacklers had an estimated net worth of $13 billion as of 2016, making them one of the richest families in the US, according to Forbes magazine.
In its filing Friday, New York told a state judge that the only way it can determine the full extent of those transfers is if all those it has subpoenaed are forced to provide documents detailing their interactions with the Sackler family.
"While the Sacklers continue to lowball victims and skirt a responsible settlement, we refuse to allow the family to misuse the courts in an effort to shield their financial misconduct," New York Attorney General Letitia James said in a statement.